Fig. 1From: Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trialTime to and duration of confirmed response. 1 L first-line, 2 L second-lineBack to article page